Technology ID
E-182-2011-0

Human Phospho-Serine134 Glucocorticoid Receptor Polyclonal Antibody: Useful for the Characterization of Glucocorticoid Signaling Processes, e.g., in Cancer and Inflammation

Linked ID
TAB-2328
Inventors
Amy Beckley (NIEHS)
John Cidlowski (NIEHS)
Lead Inventors
Amy Beckley (NIEHS)
Co-Inventors
John Cidlowski (NIEHS)
Applications
Research Materials
Medical Devices
ICs
NIEHS
Commercial Applications
  • Western analysis, immunoprecipitation, and immunofluorescence studies
The glucocorticoid receptor (GR) functions as a hormone-dependent transcription factor that is involved in the maintenance of basal and stress-related homeostasis. Serine 134 is a newly discovered phosphorylation target on the human glucocorticoid receptor that becomes phosphorylated during stress-activating conditions such as ultraviolet irradiation, nutrient starvation, and oxidative stress. The inventors have developed a rabbit polyclonal antibody that specifically recognizes the Ser 134 phosphorylated form of the human glucocorticoid receptor. This antibody may be particularly useful for a variety of basic research applications, such as the characterization and study of glucocorticoid signaling in cancer, inflammation, and other diseases.

The antibody is available as crude antisera and has been epitope purified; it has cross reactivity with human, rat, and mouse tissues.

Request More Info

Licensing Contact